Evidence map›Paper›PMID 38263017›Full record

ArticleJournal of neuroinflammation2024

Associations between sex, body mass index and the individual microglial response in Alzheimer's disease.

Gloria Biechele, Boris-Stephan Rauchmann, Daniel Janowitz, Katharina Buerger, Nicolai Franzmeier, Endy Weidinger, Selim Guersel, Sebastian Schuster, Anika Finze, Stefanie Harris and 23 more

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 24 citations in OpenAlex.

  1. Journal of neurology · 2024
    Trial
  2. Review
  3. Article
  4. Article
  5. Comparing and combining TSPO-PET tracers in tauopathies.European journal of nuclear medicine and molecular imaging · 2026
    Article
  6. Observational
  7. Defining patient-centered amyloid PET thresholds for the onset of tauopathy in Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Comparison ofEuropean journal of nuclear medicine and molecular imaging · 2025
    Article
  12. Review
  13. Review
  14. Article
  15. Sex- and region-dependent neuroinflammation in Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors at 9 institutions in 4 countries.

Gloria BiecheleDepartment of Nuclear Medicine, LMU University Hospital, LMU Munich, University of Munich, Marchioninstraße 15, 81377, Munich, Germany.
Boris-Stephan RauchmannDepartment of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany.
Daniel JanowitzInstitute for Stroke and Dementia Research, LMU University Hospital, LMU Munich, Munich, Germany.
Katharina BuergerInstitute for Stroke and Dementia Research, LMU University Hospital, LMU Munich, Munich, Germany.
Nicolai FranzmeierInstitute for Stroke and Dementia Research, LMU University Hospital, LMU Munich, Munich, Germany.
Endy WeidingerDepartment of Neurology, LMU University Hospital, LMU Munich, Munich, Germany.
Selim GuerselDepartment of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany.
Sebastian SchusterDepartment of Nuclear Medicine, LMU University Hospital, LMU Munich, University of Munich, Marchioninstraße 15, 81377, Munich, Germany.
Anika FinzeDepartment of Nuclear Medicine, LMU University Hospital, LMU Munich, University of Munich, Marchioninstraße 15, 81377, Munich, Germany.
Stefanie HarrisDepartment of Nuclear Medicine, LMU University Hospital, LMU Munich, University of Munich, Marchioninstraße 15, 81377, Munich, Germany.
Simon LindnerDepartment of Nuclear Medicine, LMU University Hospital, LMU Munich, University of Munich, Marchioninstraße 15, 81377, Munich, Germany.
Nathalie L AlbertDepartment of Nuclear Medicine, LMU University Hospital, LMU Munich, University of Munich, Marchioninstraße 15, 81377, Munich, Germany.
Christian WetzelDepartment of Psychiatry and Psychotherapy, University of Regensburg, Regensburg, Germany.
Rainer RupprechtDepartment of Psychiatry and Psychotherapy, University of Regensburg, Regensburg, Germany.
Axel RomingerDepartment of Nuclear Medicine, LMU University Hospital, LMU Munich, University of Munich, Marchioninstraße 15, 81377, Munich, Germany.
Carla PalleisGerman Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Sabrina KatzdoblerDepartment of Neurology, LMU University Hospital, LMU Munich, Munich, Germany.
Lena BurowDepartment of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany.
Carolin KurzDepartment of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany.
Mirlind ZaganjoriDepartment of Nuclear Medicine, LMU University Hospital, LMU Munich, University of Munich, Marchioninstraße 15, 81377, Munich, Germany.
Lena-Katharina TrappmannDepartment of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany.
Oliver GoldhardtDepartment of Psychiatry and Psychotherapy, School of Medicine and Health, Technical University Munich, Klinikum Rechts Der Isar, Munich, Germany.
Timo GrimmerDepartment of Psychiatry and Psychotherapy, School of Medicine and Health, Technical University Munich, Klinikum Rechts Der Isar, Munich, Germany.
Jan HaeckertDepartment of Psychiatry, Psychotherapy and Psychosomatics, Medical Faculty, University of Augsburg, Augsburg, Germany.
Daniel KeeserDepartment of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany.
Sophia StoeckleinDepartment of Radiology, LMU University Hospital, LMU Munich, Munich, Germany.
Estrella Morenas-RodriguezGerman Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Peter BartensteinDepartment of Nuclear Medicine, LMU University Hospital, LMU Munich, University of Munich, Marchioninstraße 15, 81377, Munich, Germany.
Johannes LevinGerman Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Günter U HöglingerGerman Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Mikael SimonsGerman Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Robert Perneczky *German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Matthias Brendel *Department of Nuclear Medicine, LMU University Hospital, LMU Munich, University of Munich, Marchioninstraße 15, 81377, Munich, Germany. matthias.brendel@med.uni-muenchen.de.
Ludwig-Maximilians-Universität München · DELMU Klinikum · DEMunich Cluster for Systems Neurology · DEKlinikum rechts der Isar · DEUniversity of Regensburg · DEGerman Center for Neurodegenerative Diseases · DEMax Planck Institute of Psychiatry · DEUniversity of Augsburg · DEUniversity of Bern · CH

Funding

Deutsche Forschungsgemeinschaft EXC 2145 SyNergy - ID 390857198
6 · The paper itself

Abstract

BACKGROUND AND

objectives18-kDa translocator protein position-emission-tomography (TSPO-PET) imaging emerged for in vivo assessment of neuroinflammation in Alzheimer's disease (AD) research. Sex and obesity effects on TSPO-PET binding have been reported for cognitively normal humans (CN), but such effects have not yet been systematically evaluated in patients with AD. Thus, we aimed to investigate the impact of sex and obesity on the relationship between β-amyloid-accumulation and microglial activation in AD.

methods49 patients with AD (29 females, all Aβ-positive) and 15 Aβ-negative CN (8 female) underwent TSPO-PET ([

resultsIn AD, females showed higher mean cortical TSPO-PET z-scores (0.91 ± 0.49; males 0.30 ± 0.75; p = 0.002), while Aβ-PET z-scores were similar. The Aβ-plaque-independent microglial response was stronger in females with AD (+ 0.37 ± 0.38; males with AD - 0.33 ± 0.87; p = 0.006), pronounced at the prodromal stage. On the contrary, the Aβ-plaque-dependent microglial response was not different between sexes. The Aβ-plaque-independent microglial response was significantly associated with tau-PET in females (Braak-II regions: r = 0.757, p = 0.003), but not in males. BMI and the Aβ-plaque-independent microglial response were significantly associated in females (r = 0.44, p = 0.018) but not in males (BMI*sex interaction: F

conclusionWhile microglia response to fibrillar Aβ is similar between sexes, women with AD show a stronger Aβ-plaque-independent microglia response. This sex difference in Aβ-independent microglial activation may be associated with tau accumulation. BMI is positively associated with the Aβ-plaque-independent microglia response in females with AD but not in males, indicating that sex and obesity need to be considered when studying neuroinflammation in AD.

Indexed as

Alzheimer DiseaseMicrogliaAmyloid beta-PeptidesBody Mass IndexFemaleHumansMaleNeuroinflammatory DiseasesObesityReceptors, GABAAmyloid beta-PeptidesReceptors, GABATSPO protein, humanAmyloidMicrogliaSex differencesTauTSPO

Identifiers

PMID38263017
PMCPMC10804830
OpenAlexW4391141914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.